CBOE Global Markets Q4 25 Earnings Conference Call At 8:30 AM ET

CBOE Global Markets will host a conference call at 8:30 AM ET on February 6, 2026 to discuss its fourth-quarter 2025 earnings; a live webcast will be available via the company's investor events page. The notice provides timing and access for the earnings release and management commentary but contains no financial figures or guidance, signalling only that results and related management discussion will be published and could prompt market moves upon release.

Analysis

Market structure: CBOE (CBOE) is the incumbent beneficiary if Q4 2025 shows rising options ADV or market-data revenue — more flow translates to scalable fee income; losers would be smaller ATSs/venues and listing rivals like NDAQ if CBOE regains derivatives share. A strong quarter would increase CBOE’s pricing power on execution and complex-product fees by 3–7% range over next 12 months; a weak quarter risks volume-sensitive revenue compression of similar magnitude.

Risk assessment: Immediate risk is an earnings surprise (±>5% move) and short-term implied-vol spikes; medium-term (3–12 months) tails include SEC intervention on market-data/tape fees or an exchange outage triggering fines/market share loss. Hidden dependency: ~20–40% of exchange EBITDA often comes from data/licensing — regulatory cuts to tape fees would be a multi-quarter earnings headwind. Catalysts to watch: ADV prints, data revenue growth, and SEC rule announcements in next 30–90 days.

Trade implications: For asymmetric risk, favor options over straight equity — expect a 3–7% move around the call; buy a 1-month ATM straddle sized to 0.5–1% of portfolio if you expect >6% directional move, or sell a 10–20 delta iron condor for premium if IV is >historical by 15% and you can hold 30 days. Relative-value: consider long CBOE / short NDAQ 1–2% net exposure for 3–6 months if CBOE’s derivatives revenue accelerates by >5% YOY while NDAQ’s listings/data growth lags.

Contrarian angles: Consensus will likely focus on volume and fee trends and underweight regulatory risk to data revenues — that complacency is the mispricing to exploit. Historical parallels: prior tape-fee scrutiny episodes (2018–2020) show >15% downside re-rating when data fees are cut; if CBOE discloses conservative data guidance, market can overreact and create buying windows within 48–72 hours.

Key Decisions for Investors

• Establish a tactical 1% long-equity position in CBOE (CBOE) within 24 hours pre-earnings if ADV guidance is positive; take profits or trim to 0.5% within 3 trading days post-call if stock rises >7%.
• If directional uncertainty, buy a 1-month at-the-money straddle on CBOE sized to 0.5–1.0% of portfolio before the call; set rule-based exit: close if premium declines 25% or underlying moves >8% in either direction, otherwise exit 3 trading days after results.
• Implement a 1–2% pair trade: long CBOE / short NDAQ for a 3–6 month horizon if CBOE reports derivatives revenue growth >5% YoY and NDAQ guidance is muted; unwind if CBOE ADV falls >5% YoY or NDAQ issues positive cadence/guidance raising prospects by >3%.
• Buy a protective 5–7% OTM put on CBOE expiring in 1 month if holding shares through the call; limit premium cost to <0.8% of position value and reassess after earnings to avoid long-dated carry.
• Within 30–90 days, reduce net exposure to exchange/data-sensitive positions by 50% if SEC proposes tape/market-data fee caps or if quarterly data revenue growth is cut sequentially by >3%.